← FDA Drug Approvals (Drugs@FDA)

DACTINOMYCIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: XGEN PHARMS · Approved 2019-05-20

Drug application

FDA Application #

ANDA203999

Application type

Abbreviated New Drug Application (Generic)

Brand name

DACTINOMYCIN

Generic name

DACTINOMYCIN

Active ingredients

DACTINOMYCIN

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

XGEN PHARMS

Manufacturer

XGen Pharmaceuticals DJB, Inc.

First approval

2019-05-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown